For the roughly one in ten people whose bodies never fully recovered from COVID-19, medicine has long offered little more than uncertainty. Now, researchers at Gladstone Institutes have identified something concrete: in long COVID patients, the immune cells designed to fight specific viruses bear the marks of both exhaustion and unusual destructive intensity — a paradox that may help explain why the body remains in a state of unresolved conflict long after the initial infection has passed. The discovery, which points especially toward herpesviruses and shows stronger effects in women, does not
EurekAlert!
· Jul 31, 2026
· health
· 7 min de lectura
High
Verificación: Verificado
Long COVID linked to exhausted, hyperactive immune cells targeting multiple viruses
Long COVID significantly impacts patients' quality of life, forcing some to leave work and abandon pre-COVID lifestyles due to severe, unpredictable symptoms lasting months or years.
◉
Health & Medicine
9464 artículos relacionados
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% coincidencia
Bird Flu Detected in NZ Native Bird as Pharma Giants Reshape Drug Acce…
Devdiscourse · 99% coincidencia
Experimental pancreatic cancer drug daraxonrasib doubles survival in l…
USA TODAY · 99% coincidencia
Orillia's second deadly Legionnaires outbreak in three years kills one…
National Post · 99% coincidencia
'Walking Ebola' strain's slow progression complicates Congo outbreak r…
The Straits Times · 99% coincidencia
Cobertura Relacionada
CBS News · Sep 16
NBC Los Angeles news helicopter crashes in Chatsworth, killing 3
An NBC Los Angeles news helicopter crashed in Chatsworth on Tuesday evening, killing at least three people with two othe…
BBC News · Sep 16 LA news helicopter crashes while covering bus collision; 3 deadAn NBC Los Angeles news helicopter crashed in Chatsworth while covering a deadly bus collision, killing three people abo…
The Canberra Times · Sep 16 Three killed in helicopter crash near Los AngelesAt least three people died when a helicopter crashed in Chatsworth, suburban Los Angeles, near where emergency crews wer…
Inside Precision Medicine · Sep 16 AACR Report: FDA Approves 10 Targeted Cancer Therapies in 12 MonthsThe 2026 AACR Cancer Progress Report documents FDA approval of 10 new molecularly targeted cancer therapies and companio…
Sesgo y Encuadre
⚖
Science reporting on long COVID immune mechanisms with appropriate emphasis on research findings and patient impact, minimal detectable bias.
Bias Direction
center
Confidence
HIGH
Balanced scientific journalism presenting research findings with contextual patient impact; uses expert authority (researcher interview) to establish credibility; frames long COVID as serious public health issue requiring research solutions.
Extreme fatigue
racing pulse
brain fog
entire lives turned upside down
heartbreaking ways
Perspectives from long COVID patients themselves (only paraphrased through researcher)
Viewpoints from healthcare providers treating long COVID patients
Economic/epidemiological data on long COVID burden
Perspectives questioning the prevalence estimates or severity claims
Information on ongoing clinical trials or alternative treatment approaches
Impacto Geopolítico
🌎
Medical research on long COVID immune dysfunction has no direct geopolitical implications; this is a public health discovery unrelated to international relations or power dynamics.
Escalation Risk
low
Confidence
HIGH
Lente Económico
📈
Long COVID research reveals immune dysfunction affecting millions, with potential economic impacts on healthcare costs, workforce productivity, and pharmaceutical development opportunities.
Market Signal
mixed
Confidence
MED
Healthcare and medical services
Pharmaceutical and biotechnology
Life insurance and disability insurance
Labor and workforce productivity
Mental health services
Medical research and diagnostics
Households face ongoing healthcare expenses without proven treatments, potential loss of income from work absences/disability, increased insurance premiums, and psychological burden. WHO estimates ~10% of COVID cases develop long COVID, affecting millions globally with extended treatment needs.
Governments may increase funding for long COVID research and treatment development; healthcare systems need protocols for diagnosis and management; disability and workers' compensation policies may require updates; pharmaceutical companies face regulatory incentives for therapeutic development; public health agencies must address workforce impact and healthcare burden.